Find a Top Rated Lawyer
Immediate Past Chair, ABA Health Law Section
Co-chair; member of Planning Committee, ABA National Institute on Internal Investigations and Forum for In-House Counsel, ABA National False Claim Act Trial Institute, and ABA Medical Device Institute
Editor-in-Chief, BNA pharmaceutical law treatise
Author, Several book chapters; dozens of published articles.
Assigned to Trial Practice and Health Care Practice Groups at Duane Morris
Client representation in complex civil and white collar litigation.
Lead counsel, 100+ jury trials
Lead counsel, dozens of appeals
Client representation in internal investigations
Client assistance with crisis management
Client represenation in fraud and abuse and corporate governance matters
Experience in securities and financial fraud, environmental law, and life sciences matters (among others)
Former federal and state prosecutor
Former Chief of Criminal Division, U.S. Attorney's Office, Southern District of Texas
Adjunct Professor, University of Houston Law Center
Adjunct Professor, University of Florida College of Pharmacy
Faculty instructor, NITA--Trial and deposition skill programs
Interviewed by various media sources: AP; Bloomberg Business, CBC, CNBC; CNN; Crain Chicago; Dallas Morning News; 48 Hours; Fox Financial, Health Channel; Health News Florida; Houston Chronicle; Modern Healthcare; National Law Journal; New York Law Journal; New York Times; Reuters/Thomson, Texas Lawyer; Washington Post; Wolters Kluwer; and USA Today.
Extensively published; frequently present to professional groups
LLMs in Taxation and Health Law
Board Certified (Criminal Law), Texas Board of Legal Specialization; National Board of Trial Advocacy
Super Lawyers: 2007 - 2015
Countries: China, Singapore, United Kingdom, Vietnam
Admitted: 1982, Texas
Professional Webpage: www.duanemorris.com/attorneys/michaeleclark.html
Honors and Awards:
Pro bono/Community Service:
Scholarly Lectures and Writings:
Other Outstanding Achievements:
The Responsible Corporate Officer Doctrine (The Crime of Doing Nothing) - (2011)
This paper submitted for a presentation in October 2011 at the New York State Bar Association's Fourth Corporate Counsel Institute addresses how the Responsible Corporate Officer Doctrine is being used by various agencies in administrative, civil, and criminal cases, along with some recent and provocative examples of how it has been wielded against executives in the Health Law area
This advertorial in Modern Healthcare provides a summary of the new and expanded whistleblower provisions authorized by Congress in the Dodd-Frank Act related to SEC and CFTC whistleblowers, the bounties they may receive for providing original information about securities and commodities violations, and the likely impact this will have on companies' ongoing compliance activities as well as additional litigation, civil and criminal.
Industry Group(s): Life Sciences
This firm alert addresses the new and expanded SEC and CFTC whistleblower provisions, and related measures, authorized by Congress in the Dodd-Frank Act, along with some open issues and likely consequences from these new measures
Super Lawyers is a rating service of outstanding lawyers from more than 70 practice areas who have attained a high-degree of peer recognition and professional achievement. The selection process includes independent research, peer nominations and peer evaluations.